A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein—providing a promising path for new COVID-19 therapeutics.
Jun 11, 2020
0
3
Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side ...
May 28, 2020
0
202
The coronavirus has the world in its grip. Finding a cure has never been more important. Unfortunately, the development of new drugs for treatment of the COVID-19 disease caused by the virus and development of a vaccine are ...
May 20, 2020
0
2
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules ...
Apr 14, 2020
0
59
The novel coronavirus may have K-12 students in Kentucky's school districts learning at home, but researchers at the University of Louisville are using the computing power of thousands of computers in classrooms across the ...
Apr 9, 2020
0
3
Imperial researchers will look for potential new treatments for COVID-19 using the computing power of people's smartphones.
Apr 8, 2020
0
1
New research led by hearing scientists at Oregon Health & Science University suggests an avenue to treat and prevent intractable genetic disorders before birth.
Apr 6, 2020
0
121
A team of researchers at the University of California has been studying proteins that the SARS-CoV-2 virus uses to bind to proteins in the lungs, and has identified multiple drug candidates that might be useful to treat patients ...
It's a disease that's hard to pronounce and even harder to eradicate, but schistosomiasis is worth the effort. Caused by parasitic worms carried by freshwater snails, schistosomiasis leads to about 280,000 deaths each year, ...
Feb 26, 2020
0
4
Two recently approved leukemia drugs could be enlisted against treatment-resistant lung cancer, with a clinical trial expected to launch in Toronto and Zagreb, Croatia, later this year to evaluate one of them.
Feb 24, 2020
0
122
